ETS2 and Down syndrome: While some studies have suggested that overexpression of ETS2 is associated with the craniofacial abnormalities observed in Down syndrome patients[32], Hill and colleagues found that, in general, trisomy 16 mice (model for human trisomy 21, Down syndrome) with or without an extra copy of ETS2 produced comparable craniofacial abnormalities[33].